Comparison between Akums Drugs IPO and Bansal Wire Industries IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Bansal Wire Industries IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Bansal Wire Industries IPO is up to ₹745.00 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Bansal Wire Industries IPO is ₹256.00 per share.
| Akums Drugs IPO | Bansal Wire Industries IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹5 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹243.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹256.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹256.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | |
| Market Lot Size | 22 shares | 58 shares |
| Fresh Issue Size | 1,00,37,708 shares | 2,91,01,562 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹745.00 Cr |
| OFS Issue Size | 1,73,30,435 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,73,68,143 shares | 2,91,01,562 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹745.00 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Bansal Wire Industries IPO opens on Jul 03, 2024. The closing date of Akums Drugs IPO and Bansal Wire Industries IPO is Aug 01, 2024, and Jul 05, 2024, respectively.
| Akums Drugs IPO | Bansal Wire Industries IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Jul 02, 2024 |
| Issue Open | Jul 30, 2024 | Jul 03, 2024 |
| Issue Close | Aug 01, 2024 | Jul 05, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 08, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Jul 10, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Aug 07, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Oct 06, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Bansal Wire Industries IPO P/E ratio of 41.41.
| Akums Drugs IPO | Bansal Wire Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 95.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 77.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 41.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹4007.83 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 21.19% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 18.46% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | 1.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.18 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 18.27% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Bansal Wire Industries IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 58,20,312 shares in Bansal Wire Industries IPO.
| Akums Drugs IPO | Bansal Wire Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 87,30,468 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 58,20,312 shares |
| NII | 40,68,637 shares | 43,65,235 shares |
| RII | 27,12,424 shares | 1,01,85,547 shares |
| Employee | 2,43,902 shares | |
| Others | ||
| Total | 2,73,68,151 shares | 2,91,01,562 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Bansal Wire Industries IPO subscribed 62.76x.
| Akums Drugs IPO | Bansal Wire Industries IPO | |
|---|---|---|
| QIB (times) | 90.09x | 153.86x |
| NII (times) | 42.10x | 54.21x |
| Big NII (times) | 47.43x | 55.27x |
| Small NII (times) | 31.45x | 52.11x |
| RII (times) | 20.80x | 14.37x |
| Employee (times) | 4.14x | |
| Other (times) | ||
| Total (times) | 63.44x | 62.76x |
